The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Loirat, D.
Right arrow Articles by Michel, M.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Loirat, D.
Right arrow Articles by Michel, M.-L.
The Journal of Immunology, 2000, 165: 4748-4755.
Copyright © 2000 by The American Association of Immunologists

Multiepitopic HLA-A*0201-Restricted Immune Response Against Hepatitis B Surface Antigen After DNA-Based Immunization

Delphine Loirat1,*,{dagger}, François A. Lemonnier{ddagger} and Marie-Louise Michel2,*

* Unité de Recombinaison et Expression Génétique, Institut National de la Santé et de la Recherche Médicale, Unité 163, Institut Pasteur, Paris, France; {dagger} IDM, Immuno-Designed Molecules, Paris, France; and {ddagger} Unité d’Immunité Cellulaire Antivirale, Institut Pasteur, Paris, France

CTL together with anti-envelope Abs represent major effectors for viral clearance during hepatitis B virus (HBV) infection. The induction of strong cytotoxic and Ab responses against the envelope proteins after DNA-based immunization has been proposed as a promising therapeutic approach to mediate viral clearance in chronically infected patients. Here, we studied the CTL responses against previously described hepatitis B surface Ag (HBsAg)-HLA-A*0201-restricted epitopes after DNA-based immunization in HLA-A*0201 transgenic mice. The animal model used was Human Human Db (HHD) mice, which are deficient for mouse MHC class I molecules (ß2-microglobulin-/- Db-/-) and transgenic for a chimeric HLA-A*0201/Db molecule covalently bound to the human ß2-microglobulin (HHD+/+). Immunization of these mice with a DNA vector encoding the small and the middle HBV envelope proteins carrying HBsAg induced CTL responses against several epitopes in each animal. This study performed on a large number of animals described dominant epitopes with specific CTL induced in all animals and others with a weaker frequency of recognition. These results confirmed the relevance of the HHD transgenic mouse model in the assessment of vaccine constructs for human use. Moreover, genetic immunization of HLA-A2 transgenic mice generates IFN-{gamma}-secreting CD8+ T lymphocytes specific for endogenously processed peptides and with recognition specificities similar to those described during self-limited infection in humans. This suggests that responses induced by DNA immunization could have the same immune potential as those developing during natural HBV infection in human patients.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
L. T. Mars, J. Bauer, D. A. Gross, F. Bucciarelli, H. Firat, D. Hudrisier, F. Lemonnier, K. Kosmatopoulos, and R. S. Liblau
CD8 T Cell Responses to Myelin Oligodendrocyte Glycoprotein-Derived Peptides in Humanized HLA-A*0201-Transgenic Mice
J. Immunol., October 15, 2007; 179(8): 5090 - 5098.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Blancou, R. Mallone, E. Martinuzzi, S. Severe, S. Pogu, G. Novelli, G. Bruno, B. Charbonnel, M. Dolz, L. Chaillous, et al.
Immunization of HLA Class I Transgenic Mice Identifies Autoantigenic Epitopes Eliciting Dominant Responses in Type 1 Diabetes Patients
J. Immunol., June 1, 2007; 178(11): 7458 - 7466.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. Mancini-Bourgine, F. Bayard, P. Soussan, Q. Deng, Y.-C. Lone, D. Kremsdorf, and M.-L. Michel
Hepatitis B Virus Splice-Generated Protein Induces T-Cell Responses in HLA-Transgenic Mice and Hepatitis B Virus-Infected Patients
J. Virol., May 15, 2007; 81(10): 4963 - 4972.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. D. Robek, M. L. Garcia, B. S. Boyd, and F. V. Chisari
Role of Immunoproteasome Catalytic Subunits in the Immune Response to Hepatitis B Virus
J. Virol., January 15, 2007; 81(2): 483 - 491.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Hu, X. Peng, T. D. Schell, L. R. Budgeon, N. M. Cladel, and N. D. Christensen
An HLA-A2.1-Transgenic Rabbit Model to Study Immunity to Papillomavirus Infection
J. Immunol., December 1, 2006; 177(11): 8037 - 8045.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
O. Adotevi, K. Mollier, C. Neuveut, S. Cardinaud, E. Boulanger, B. Mignen, W.-H. Fridman, M. Zanetti, P. Charneau, E. Tartour, et al.
Immunogenic HLA-B*0702-Restricted Epitopes Derived from Human Telomerase Reverse Transcriptase That Elicit Antitumor Cytotoxic T-Cell Responses.
Clin. Cancer Res., May 15, 2006; 12(10): 3158 - 3167.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
W.-P. Woo, T. Doan, K. A. Herd, H.-J. Netter, and R. W. Tindle
Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes.
J. Virol., April 1, 2006; 80(8): 3975 - 3984.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Takaki, M. P. Marron, C. E. Mathews, S. T. Guttmann, R. Bottino, M. Trucco, T. P. DiLorenzo, and D. V. Serreze
HLA-A*0201-Restricted T Cells from Humanized NOD Mice Recognize Autoantigens of Potential Clinical Relevance to Type 1 Diabetes.
J. Immunol., March 1, 2006; 176(5): 3257 - 3265.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Schirmbeck, P. Riedl, N. Fissolo, F. A. Lemonnier, A. Bertoletti, and J. Reimann
Translation from Cryptic Reading Frames of DNA Vaccines Generates an Extended Repertoire of Immunogenic, MHC Class I-Restricted Epitopes
J. Immunol., April 15, 2005; 174(8): 4647 - 4656.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
D. Loirat, M. Mancini-Bourgine, J.-P. Abastado, and M.-L. Michel
HBsAg/HLA-A2 transgenic mice: a model for T cell tolerance to hepatitis B surface antigen in chronic hepatitis B virus infection
Int. Immunol., October 1, 2003; 15(10): 1125 - 1136.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. Chun, J. Lee, H. S. Cheong, and K.-Y. Lee
Tumor Eradication by Hepatitis B Virus X Antigen-Specific CD8+ T Cells in Xenografted Nude Mice
J. Immunol., February 1, 2003; 170(3): 1183 - 1190.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
D. Marsac, D. Loirat, C. Petit, O. Schwartz, and M.-L. Michel
Enhanced Presentation of Major Histocompatibility Complex Class I-Restricted Human Immunodeficiency Virus Type 1 (HIV-1) Gag-Specific Epitopes after DNA Immunization with Vectors Coding for Vesicular Stomatitis Virus Glycoprotein- Pseudotyped HIV-1 Gag Particles
J. Virol., June 27, 2002; 76(15): 7544 - 7553.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. J. Palmowski, E. M.-L. Choi, I. F. Hermans, S. C. Gilbert, J.-L. Chen, U. Gileadi, M. Salio, A. Van Pel, S. Man, E. Bonin, et al.
Competition Between CTL Narrows the Immune Response Induced by Prime-Boost Vaccination Protocols
J. Immunol., May 1, 2002; 168(9): 4391 - 4398.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
C. Brinster, M. Chen, D. Boucreux, G. Paranhos-Baccala, P. Liljestrom, F. Lemmonier, and G. Inchauspe
Hepatitis C virus non-structural protein 3-specific cellular immune responses following single or combined immunization with DNA or recombinant Semliki Forest virus particles
J. Gen. Virol., February 1, 2002; 83(2): 369 - 381.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.